You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HCV Genotype 2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C, Chronic Trial in Taiwan (P1101 + Ribavirin)

Recruiting
  • Hepatitis C, Chronic
  • P1101 + Ribavirin
  • Chiayi City, Taiwan
  • +7 more
Jun 30, 2022

Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

Completed
  • Hepatitis C
  • Bradford, United Kingdom
  • +3 more
Jan 4, 2023

Chronic Hepatitis C Virus (HCV) Infection Trial (ABT-493/ABT-530, Placebo for ABT-493/ABT-530)

Completed
Has Results
  • Chronic Hepatitis C Virus (HCV) Infection
  • (no location specified)
Jul 14, 2021

Chronic Hepatitis C Virus Infection Trial in China, Korea, Republic of, Taiwan (P1101 + Ribavirin, PEG-Intron + Ribavirin)

Completed
  • Chronic Hepatitis C Virus Infection
  • P1101 + Ribavirin
  • PEG-Intron + Ribavirin
  • Beijing, China
  • +38 more
Jan 14, 2022

Hepatitis C Trial in Rotterdam (Peginterferon alfa-2a, Interferon alfa-2a, Ribavirin)

Completed
  • Hepatitis C
  • Peginterferon alfa-2a
  • +2 more
  • Rotterdam, Netherlands
    Erasmus Medical Center
Aug 26, 2021

HCV, Hepatitis C Infection, Genotype 4 Trial (2 DAA, RBV)

Completed
Has Results
  • HCV
  • +2 more
  • (no location specified)
Jul 28, 2021

Chronic Hepatitis C Virus Infection Trial (OBV/PTV/r, Sofosbuvir, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Virus Infection
  • (no location specified)
Jul 8, 2021

Hepatitis C Virus Trial (ABT-450/r/ABT-267, Ribavirin)

Completed
Has Results
  • Hepatitis C Virus
  • (no location specified)
Jul 28, 2021

Hepatitis C Infection, HIV Infection Trial in Washington, Bethesda (Nitazoxanide With Pegylated Interferon And Ribavirin)

Completed
Has Results
  • Hepatitis C Infection
  • HIV Infection
  • Nitazoxanide With Pegylated Interferon And Ribavirin
  • Washington, District of Columbia
  • +3 more
Sep 14, 2021

Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with

Completed
Has Results
  • Hepatitis C Virus Infection
  • +3 more
  • ABT-493 coformulated with ABT-530
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C, HCV, Hepatitis C Virus Trial (glecaprevir/pibrentasvir)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Hepatitis C, Chronic Trial in Taiwan (PEGASYS 180 µg Q1W, P1101 180 µg Q1W, 48 doses, P1101 270µg Q1W, 48 doses)

Completed
  • Hepatitis C, Chronic
  • PEGASYS 180 µg Q1W
  • +3 more
  • Changhua, Taiwan
  • +12 more
Oct 7, 2021

Chronic Hepatitis Trial in Italy (Peginterferon alpha-2a + Ribavirin)

Completed
  • Chronic Hepatitis
  • Peginterferon alpha-2a + Ribavirin
  • Avellino, Italy
  • +34 more
Mar 9, 2022

Hepatitis C, HCV Trial in San Antonio (TD-6450, Placebo)

Completed
  • Hepatitis C
  • HCV
  • San Antonio, Texas
    Texas Liver Institute
Jan 15, 2021

Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir)

Completed
Has Results
  • Hepatitis C Virus (HCV)
  • San Diego, California
  • +24 more
Jul 14, 2021

Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12

Active, not recruiting
  • Hepatitis C Virus (HCV)
    • Chelyabinsk, Russian Federation
    • +9 more
    Mar 1, 2022

    HIV Infection, Hepatitis C Infection Trial in Puerto Rico, United States (Nitazoxanide (NTZ), Pegylated interferon alfa-2a

    Completed
    Has Results
    • HIV Infection
    • Hepatitis C Infection
    • Nitazoxanide (NTZ)
    • +2 more
    • Birmingham, Alabama
    • +17 more
    Nov 2, 2021

    NSCLC Stage IV, HIV, HBV Trial in Verona (Nivolumab and Ipilimumab)

    Not yet recruiting
    • NSCLC Stage IV
    • +4 more
    • Nivolumab and Ipilimumab
    • Verona, Veneto/Verona, Italy
      Centro Ricerche Cliniche
    Oct 26, 2022

    Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

    Completed
    Has Results
    • Chronic Hepatitis C
    • +2 more
    • (no location specified)
    Jul 9, 2021

    Zepatier in Patients With Substance Use

    Active, not recruiting
    • Hepatitis C
    • +3 more
    • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
    • Chicago, Illinois
      University of Illinois at Chicago
    Jun 28, 2022

    Acute Coronary Syndrome, CYP2C19 Polymorphism Trial in Nieuwegein (Clopidogrel)

    Recruiting
    • Acute Coronary Syndrome
    • CYP2C19 Polymorphism
    • Nieuwegein, Utrecht, Netherlands
      St. Antonius Hospital
    Jun 27, 2023

    Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C Trial in Bucuresti (Bemnifosbuvir, Ruzasvir)

    Recruiting
    • Chronic Hepatitis C Virus
    • +4 more
    • Bucuresti, BUC, Romania
      Atea Study Site
    Jun 15, 2023

    Hepatitis C Trial in Seoul

    Completed
    • Hepatitis C
      • Seoul, Korea, Republic of
        Local Institution
      Jan 6, 2022

      Liver Cirrhosis Trial in Bunkyo-Ku (Foscenvivint)

      Not yet recruiting
      • Liver Cirrhosis
      • Bunkyo-Ku, Tokyo, Japan
        Tokyo Metropolitan Komagome Hospital
      Nov 29, 2023

      Hepatitis C Virus Infection, Response to Therapy of Trial in Canada, United States (Test and treat plus peer mentors, Usual

      Recruiting
      • Hepatitis C Virus Infection, Response to Therapy of
      • Test and treat plus peer mentors
      • Usual care
      • Birmingham, Alabama
      • +3 more
      Dec 9, 2022